Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 88.77 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 88.77 Bn
Jun 30, 2026 87.63 Bn
Mar 31, 2026 86.48 Bn
Dec 31, 2025 90.04 Bn
Sep 30, 2025 96.89 Bn
Jun 30, 2025 94.68 Bn
Mar 31, 2025 92.43 Bn
Dec 31, 2024 92.60 Bn
Sep 30, 2024 93.67 Bn
Jun 30, 2024 94.65 Bn
Mar 31, 2024 99.03 Bn
Dec 31, 2023 95.16 Bn
Sep 30, 2023 91.26 Bn
Jun 30, 2023 93.49 Bn
Mar 31, 2023 94.28 Bn
Dec 31, 2022 96.82 Bn
Sep 30, 2022 98.20 Bn
Jun 30, 2022 100.36 Bn
Mar 31, 2022 103.03 Bn
Dec 31, 2021 109.31 Bn
API Access

Bristol Myers Squibb Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY